Exogenous ALLO supplementation improves the depression- and anxiety-like behaviors in rats exposed to chronic stress and its beneficial effects are secondary to increased BDNF levels in the brain (Evans et al. 2012). The gene discussed is BDNF; the disease is depressive disorder.